Follow
Isofol Medical AB
Nasdaq First North GM (Sweden)
Isofol Medical AB is a pharmaceutical company. It is a manufacturer of folate-based therapies. The company's drug candidate Modufolin enhances the effect of the current chemotherapy treatment for patients treated for colorectal cancer. It's products used for increase efficacy and reduce the side effects of antimetabolite cancer treatment.
Sector:
HEALTH CARE
>
Biotechnology
Healthcare
Instruments & Events
The shares and options available for this company. Including past events like IPOs, direct listings and exercise periods.
Type
Ticker
ISIN
Market
SHARE
ISOFOL
SE0009581051
Nasdaq First North GM
Sweden (SE)
Details of share in Isofol Medical AB with ticker ISOFOL
Status
Active
Order book id
Amount of instruments
83 365 966
Par value
0.0300
Market cap
Currency
SEK
Segment
First North Premier
First trading date
04 Apr 2017
Terms
Type
Price
Pre-money valuation
Time
Files
IPO
29.00 SEK
487M SEK
21 Mar - 03 Apr 2017
IPO in Isofol Medical AB
Type
Price
Pre-money valuation
Time
Files
New issue
3.50 SEK
112.19M SEK
18 May - 01 Jun 2020
Share issue in Isofol Medical AB
People
Number of Employees
12 people
Anders Rabbe
CEO
Ulf Jungnelius
Chairman of the board
Ulf Jungnelius
Board member
Bengt Gustavsson
Board member
Anders Vedin
Board member
Magnus Björsne
Board member
Paula Boultbee
Board member
Jonas Pedersén
Board member
Alain Herrera
Board member
Company Details
Sector
HEALTH CARE
Website

Address
Arvid Wallgrens Backe 20 5tr
Zip code
413 46
City/district
Gothenburg
Country
Sweden (SE)
Registration number
556759-8064
LEI code
549300MCXYAHG7VBHX75
First trade date
04 Apr 2017
Registration date
19 Jun 2008
Short name
Isofol Medical

We use cookies to make your experience using IPOhub better. By using our site you agree to our use of cookies. Learn More

Create Your FREE Account to stay Up To Date